Cargando…

Blockade of the P2Y2 Receptor Attenuates Alcoholic Liver Inflammation by Targeting the EGFR-ERK1/2 Signaling Pathway

PURPOSE: It is well known that inflammation plays a key role in complex pathological progressions of alcohol-associated liver disease (ALD). To date, effective therapy for ALD is lacking. P2Y2 receptor (P2Y2R), a G protein-coupled P2Y purinergic receptor, represents a novel pharmacological target in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Zhen-Ni, Su, Qian-Qian, Wang, Yu-Hui, Wu, Xue, Lv, Xiong-Wen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013714/ https://www.ncbi.nlm.nih.gov/pubmed/35444406 http://dx.doi.org/10.2147/DDDT.S346376

Ejemplares similares

CD73 Attenuates Alcohol-Induced Liver Injury and Inflammation via Blocking TLR4/MyD88/NF-κB Signaling Pathway
por: Liu, Zhen-Ni, et al.
Publicado: (2022)

Dual blockade of EGFR and ERK1/2 phosphorylation potentiates growth inhibition of breast cancer cells
por: Lev, D C, et al.
Publicado: (2004)

P2X7 Receptor in Alcoholic Steatohepatitis and Alcoholic Liver Fibrosis
por: Xia, Guo-Qing, et al.
Publicado: (2022)

Macrophage Sphingosine 1-Phosphate Receptor 2 Blockade Attenuates Liver Inflammation and Fibrogenesis Triggered by NLRP3 Inflammasome
por: Hou, Lei, et al.
Publicado: (2020)

Liver Fibrosis and Inflammation under the Control of ERK2
por: Jeng, Kuo-Shyang, et al.
Publicado: (2020)

Inhibition of MD2‐dependent inflammation attenuates the progression of non‐alcoholic fatty liver disease
por: Zhang, Yali, et al.
Publicado: (2017)

GLP-2 Attenuates LPS-Induced Inflammation in BV-2 Cells by Inhibiting ERK1/2, JNK1/2 and NF-κB Signaling Pathways
por: Li, Nan, et al.
Publicado: (2016)

P2Y2 Receptor and EGFR Cooperate to Promote Prostate Cancer Cell Invasion via ERK1/2 Pathway
por: Li, Wei-Hua, et al.
Publicado: (2015)

Attenuation of Laser-Induced Choroidal Neovascularization by Blockade of Prostaglandin D(2) Receptor 2
por: Soga, Hirotsugu, et al.
Publicado: (2023)

Blockade of neuronal dopamine D2 receptor attenuates morphine tolerance in mice spinal cord
por: Dai, Wen-Ling, et al.
Publicado: (2016)

Erk2 but not Erk1 regulates crosstalk between Met and EGFR in squamous cell carcinoma cell lines
por: Gusenbauer, Simone, et al.
Publicado: (2015)

Onion Bulb Extract Downregulates EGFR/ERK1/2/AKT Signaling Pathway and Synergizes With Steroids to Inhibit Allergic Inflammation
por: El-Hashim, Ahmed Z., et al.
Publicado: (2020)

Blockade of thymic stromal lymphopoietin and CRTH2 attenuates airway inflammation in a murine model of allergic asthma
por: Lee, Hea Yon, et al.
Publicado: (2020)

Caveolin-1 Alleviates Acetaminophen—Induced Hepatotoxicity in Alcoholic Fatty Liver Disease by Regulating the Ang II/EGFR/ERK Axis
por: Xin, Jiao, et al.
Publicado: (2022)

A novel mechanism of ERK1/2 regulation in smooth muscle involving acetylation of the ERK1/2 scaffold IQGAP1
por: Vetterkind, Susanne, et al.
Publicado: (2017)

Anti-Invasive and Anti-Migratory Effects of Ononin on Human Osteosarcoma Cells by Limiting the MMP2/9 and EGFR-Erk1/2 Pathway
por: Gong, Guowei, et al.
Publicado: (2023)

Involvement of EGFR, ERK-1,2 and AKT-1,2 Activity on Human Glioma Cell Growth
por: Allahverdi, Amir, et al.
Publicado: (2020)

Blockade of integrin α3 attenuates human pancreatic cancer via inhibition of EGFR signalling
por: Lee, Jungwhoi, et al.
Publicado: (2019)

The Role of ERK1/2 in the Development of Diabetic Cardiomyopathy
por: Xu, Zheng, et al.
Publicado: (2016)

Sustained activation of EGFR-ERK1/2 signaling limits the response to tigecycline-induced mitochondrial respiratory deficiency in liver cancer
por: Zhou, Yangyang, et al.
Publicado: (2022)

Blockade of myeloid differentiation protein 2 prevents obesity‐induced inflammation and nephropathy
por: Fang, Qilu, et al.
Publicado: (2017)

Parecoxib attenuates inflammation injury in septic H9c2 cells by regulating the MAPK signaling pathway
por: Qian, Xin, et al.
Publicado: (2023)

Hierarchical scaffolding of an ERK1/2 activation pathway
por: Vetterkind, Susanne, et al.
Publicado: (2013)

The ERK(1/2) Inhibitor U0126 Attenuates Diabetes-Induced Upregulation of MMP-9 and Biomarkers of Inflammation in the Retina
por: Mohammad, Ghulam, et al.
Publicado: (2013)

Central blockade of salusin β attenuates hypertension and hypothalamic inflammation in spontaneously hypertensive rats
por: Li, Hong-Bao, et al.
Publicado: (2015)

Anexelekto (AXL) Increases Resistance to EGFR-TKI and Activation of AKT and ERK1/2 in Non-Small Cell Lung Cancer Cells
por: Tian, Yaqiong, et al.
Publicado: (2016)

Isoform-Specific Roles of ERK1 and ERK2 in Arteriogenesis
por: Ricard, Nicolas, et al.
Publicado: (2019)

RNF128 Promotes Malignant Behaviors via EGFR/MEK/ERK Pathway in Hepatocellular Carcinoma
por: Bai, Xue-Song, et al.
Publicado: (2020)

Knockout of Purinergic P2Y(6) Receptor Fails to Improve Liver Injury and Inflammation in Non-Alcoholic Steatohepatitis
por: Nishiyama, Kazuhiro, et al.
Publicado: (2023)

Sprouty2 Suppresses Epithelial-Mesenchymal Transition of Human Lens Epithelial Cells through Blockade of Smad2 and ERK1/2 Pathways
por: Tan, Xuhua, et al.
Publicado: (2016)

EGFR/SRC/ERK-stabilized YTHDF2 promotes cholesterol dysregulation and invasive growth of glioblastoma
por: Fang, Runping, et al.
Publicado: (2021)

Bicyclol Regulates Hepatic Gluconeogenesis in Rats with Type 2 Diabetes and Non-alcoholic Fatty Liver Disease by Inhibiting Inflammation
por: Li, Hongxue, et al.
Publicado: (2021)

δ-Catenin Increases the Stability of EGFR by Decreasing c-Cbl Interaction and Enhances EGFR/Erk1/2 Signaling in Prostate Cancer
por: Shrestha, Nensi, et al.
Publicado: (2018)

Fenofibrate Attenuated Glucose-Induced Mesangial Cells Proliferation and Extracellular Matrix Synthesis via PI3K/AKT and ERK1/2
por: Zeng, Rui, et al.
Publicado: (2013)

A novel prostaglandin I(2) agonist, ONO-1301, attenuates liver inflammation and suppresses fibrosis in non-alcoholic steatohepatitis model mice
por: Motegi, Satoko, et al.
Publicado: (2022)

Small interfering RNA against ERK1/2 attenuates cigarette smoke-induced pulmonary vascular remodeling
por: Yu, Muqing, et al.
Publicado: (2017)

cyy-287, a novel pyrimidine-2,4-diamine derivative, inhibits tumor growth of EGFR-driven non-small cell lung cancer via the ERK pathway
por: Zhang, Qianwen, et al.
Publicado: (2022)

Blockade of CCN4 attenuates CCl(4)-induced liver fibrosis
por: Li, Xiaofei, et al.
Publicado: (2015)

ERK1/2 communicates GPCR and EGFR signaling pathways to promote CTGF-mediated hypertrophic cardiomyopathy upon Ang-II stimulation
por: Liu, Xin, et al.
Publicado: (2019)

Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer
por: Van Emburgh, Beth O., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_u2mcurhimsp9bafftf49h4523i